A recent study showed that CD4+CD39+ Tregs produce adenosine by exposure to CD39+CD73+ exosomes from plasma in patients with HNSCC, thereby supporting tumor immune escape (90). This evidence concerns the gene ENTPD1 and head and neck squamous cell carcinoma.